サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1611232

血液検査の市場規模、シェア、動向分析レポート：検査タイプ別、地域別、セグメント予測、2025年～2030年

Blood Testing Market Size, Share & Trends Analysis Report By Test Type (Glucose, Lipid, COVID-19, A1C, CRP, Vitamin-D, ALT, AST, Thyroid Stimulating Hormone, PSA, Cortisol), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
血液検査の市場規模、シェア、動向分析レポート：検査タイプ別、地域別、セグメント予測、2025年～2030年
出版日: 2024年11月25日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血液検査市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の血液検査市場規模は2025～2030年にかけてCAGR 8.83%を記録し、2030年には1,605億米ドルに達すると推定されています。

同市場の成長は、感染因子の特定に対する需要の高まりや、政府や規制機関による医療支出の増加など、さまざまな要因に起因しています。さらに、糖尿病、COVID-19、心血管疾患などの感染症有病率の上昇が市場成長を促進すると予測されています。例えば、2022年のCDCによると、米国では約3,730万人が糖尿病と診断され、人口の11.3%を占めています。

このような糖尿病の有病率の増加は、血液検査に対する大きな需要を生み出し、市場の成長に寄与しています。さらに、血液検査に使用される製品の技術的進歩が市場の成長を後押ししています。患者が便利でどこでも定期検診を行うことができる携帯型グルコース測定器が利用できるようになったことが、市場の拡大に寄与しています。さらに、糖尿病患者の外科手術の前には糖尿病のモニタリングが重要であり、これがこれらの製品の需要をさらに押し上げています。新製品の採用は、予測期間中の市場成長を促進すると予想されます。

例えば、2022年5月、Labcorpは、Labcorp OnDemandによる自宅採取キットを発表しました。このキットにより、個人は少量の血液サンプルからヘモグロビンA1c（HbA1c）値を測定し、糖レベルをモニターすることができます。American Red Cross、New York Blood Center、America's Blood Centers、Armed Services Blood Program、AABB、Blood Centers of Americaなどの主要団体は、血漿の採取と提供に関する情報を提供する上で重要な役割を果たしています。献血の増加は、移植前と移植後の処置で使用される検査製品の需要をさらに促進し、それによって市場の成長を後押しすると予想されます。

血液検査市場レポートハイライト

  • グルコース検査セグメントが2024年に最大の収益シェアを占めました。このセグメントの成長を支えているのは、I型糖尿病とII型糖尿病の有病率の増加と、遺伝性糖尿病に関連する症例数の増加です。
  • 技術の絶え間ない進歩は、革新的な血液検査法や機器の開発につながりました。ポイントオブケア検査、ウェアラブル機器、検査室での検査技術の向上など、これらの進歩が市場成長の原動力となっています。
  • 北米は2024年に最大の収益シェアを占め、予測期間中もその地位を維持すると予測されるが、アジア太平洋は2025～2030年にかけて著しい成長を遂げると予測されます。
  • 事業を展開する主要参入企業は、存在感を維持するために製品の発売と地理的拡大に注力しています。例えば、2023年3月、Appleは非侵襲的血糖モニタリング技術の開発で注目すべき進歩を遂げ、糖尿病やその他の疾患を持つ個人が皮膚刺しや従来の血液検査法を必要とせずに血糖値を測定できるようにしました。
  • 2022年6月、Apollo Cancer CentersはDatar Cancer Geneticsと共同で、無症状の人の早期乳がんを検出できる血液検査を発表しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 産業分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析

第4章 採血場所のビジネス分析

  • 血液検査市場：採血場所ダッシュボード
  • 血液検査市場：採血場所の変動分析
  • 血液検査市場（採取場所別、収益別）
  • グルコース検査
    • グルコース検査市場、2018～2030年
  • A1C検査
    • A1C検査市場、2018～2030年
  • 直接LDL検査
    • 直接LDL検査市場、2018～2030年
  • 脂質パネル検査
    • 脂質パネル検査市場、2018～2030年
  • 前立腺特異抗原検査
    • 前立腺特異抗原検査市場、2018～2030年
  • COVID-19検査
    • COVID-19検査市場、2018～2030年
  • BUN検査
    • BUN検査市場、2018～2030年
  • ビタミンD検査
    • ビタミンD検査市場、2018～2030年
  • 甲状腺刺激ホルモン（TSH）検査
    • 甲状腺刺激ホルモン（TSH）検査市場、2018～2030年
  • 血清ニコチン/コチニン検査
    • 血清ニコチン/コチニン検査市場、2018～2030年
  • 高感度CRP検査
    • 高感度CRP検査市場、2018～2030年
  • 検査ステロン検査
    • 検査ステロン検査市場、2018～2030年
  • ALT検査
    • ALT検査市場、2018～2030年
  • コルチゾール検査
    • コルチゾール検査市場、2018～2030年
  • クレアチニン検査
    • クレアチニン検査市場、2018～2030年
  • AST検査
    • AST検査市場、2018～2030年
  • その他の血液検査
    • その他の血液検査市場、2018～2030年

第5章 地域ビジネス分析

  • 地域別血液検査市場シェア、2024年と2030年
  • 北米
    • 北米の血液検査市場、2018～2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州の血液検査市場、2018～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
    • ロシア
  • アジア太平洋
    • アジア太平洋の血液検査市場、2018～2030年
    • 中国
    • インド
    • 日本
    • タイ
    • 韓国
    • シンガポール
  • ラテンアメリカ
    • ラテンアメリカの血液検査市場、2018～2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカの血液検査市場、2018～2030年
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 企業分類
  • 戦略マッピング
  • 企業市場シェア分析、2024年
  • 企業プロファイル/上場企業
    • Abbott
    • bioMerieux
    • Quest Diagnostics Incorporated
    • Biomerica, Inc
    • BD
    • QIAGEN Siemens Healthineers AG
    • Danaher Corporation
    • Trinity BIoTech Plc
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Blood Testing Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 5 North America Blood Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 6 North America Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 8 Canada Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 9 Mexico Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 10 Europe Blood Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 11 Europe Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 12 France Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 13 Germany Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 14 UK Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 15 Spain Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 16 France Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 17 Italy Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 18 Sweden Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 19 Norway Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 20 Denmark Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific Blood Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 22 Asia Pacific Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 23 Japan Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 24 China Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 25 India Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 26 South Korea Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 27 Australia Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 28 Thailand Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 29 Latin America Blood Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 30 Latin America Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 31 Brazil Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 32 Argentina Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 33 MEA Blood Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 34 MEA Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 35 South Africa Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 36 Saudi Arabia Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 37 UAE Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 38 Kuwait Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Blood Testing Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Blood testing market: Testing type outlook and key takeaways
  • Fig. 15 Blood testing market: Testing type movement analysis & market share 2024 & 2030
  • Fig. 16 Glucose testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 A1C testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Direct LDL testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Lipid panel testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 PSA testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 COVID-19 testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 BUN testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Vitamin D testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 TSH testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Serum nicotine/cotinine testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 CRP testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Testosterone testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 ALT testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Cortisol testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Creatinine testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 AST testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Other blood testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Regional Outlook, 2024 & 2030
  • Fig. 34 Regional Market Dashboard
  • Fig. 35 Regional Market Place: Key Takeaways
  • Fig. 36 North America, SWOT Analysis
  • Fig. 37 Europe, SWOT Analysis
  • Fig. 38 Asia Pacific, SWOT Analysis
  • Fig. 39 Latin America, SWOT Analysis
  • Fig. 40 MEA, SWOT Analysis
  • Fig. 41 North America
  • Fig. 42 North America Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 43 U.S.
  • Fig. 44 U.S. Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Canada
  • Fig. 46 Canada Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico
  • Fig. 48 Mexico Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Europe
  • Fig. 50 Europe Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 51 UK
  • Fig. 52 UK Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Germany
  • Fig. 54 Germany Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Italy
  • Fig. 56 Italy Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 57 France
  • Fig. 58 France Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Spain
  • Fig. 60 Spain Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Sweden
  • Fig. 62 Sweden Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Norway
  • Fig. 64 Norway Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Denmark
  • Fig. 66 Denmark Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Asia Pacific
  • Fig. 68 Asia-Pacific Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 69 China
  • Fig. 70 China Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 71 India
  • Fig. 72 India Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Japan
  • Fig. 74 Japan Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Australia
  • Fig. 76 Australia Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Thailand
  • Fig. 78 Thailand Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 79 South Korea
  • Fig. 80 South Korea Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America
  • Fig. 82 Latin America Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil
  • Fig. 84 Brazil Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Argentina
  • Fig. 86 Argentina Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 87 MEA
  • Fig. 88 MEA Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 89 UAE
  • Fig. 90 UAE Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 91 South Africa
  • Fig. 92 South Africa Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Saudi Arabia
  • Fig. 94 Saudi Arabia Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Kuwait
  • Fig. 96 Kuwait Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Strategy Mapping
目次
Product Code: 978-1-68038-897-8

Blood Testing Market Growth & Trends:

The global blood testing market size is estimated to reach USD 160.50 billion by 2030, registering a CAGR of 8.83% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributable to various factors including the growing demand for the identification of infectious agents and increased healthcare spending by government and regulatory bodies. Furthermore, the rising prevalence of infectious diseases, such as diabetes, COVID-19, and cardiovascular diseases, is anticipated to drive market growth. For instance, according to the CDC in 2022, approximately 37.3 million people were diagnosed with diabetes in the United States, accounting for 11.3 % of the population.

This increasing prevalence of diabetes creates a significant demand for blood tests, thus contributing to the growth of the market. Furthermore, technological advancement in the products used for blood testing fuels the growth of the market. The availability of portable glucose meters that enable patients to perform routine checkups conveniently and anywhere has contributed to an expansion of the market. In addition, the monitoring of diabetes is crucial prior to any surgical intervention for patients with diabetes, which further drives the demand for these products. The introduction of new products is anticipated to fuel market growth over the projection period.

For instance, in May 2022, Labcorp introduced an at-home collection kit with Labcorp OnDemand, which allows individuals to measure their hemoglobin A1c (HbA1c) levels from a small blood sample to monitor their sugar levels. Key organizations, such as the American Red Cross, the New York Blood Center, America's Blood Centers, Armed Services Blood Program, AABB, and Blood Centers of America, play a crucial role in providing information on plasma collection and delivery. The rise in blood donations is expected to further drive the demand for testing products used in pre-transplant and post-transplant procedures, thereby boosting market growth.

Blood Testing Market Report Highlights:

  • The glucose testing segment held the largest revenue share in 2024. The segment growth is supported by the increasing prevalence of both type I and type II diabetes, along with the growing number of cases related to hereditary diabetes
  • Continuous advancements in technology have led to the development of innovative blood testing methods and devices. These advancements, such as point-of-care testing, wearable devices, and improved laboratory testing techniques, drive market growth.
  • North America held the largest revenue share in 2024 and is expected to maintain its position throughout the forecast period; however, Asia Pacific is expected to grow at a significant rate from 2025 to 2030
  • Key players operating are focusing on product launches and geographical expansion to maintain their presence. For instance, in March 2023, Apple made notable progress in the development of non-invasive blood glucose monitoring technology, enabling individuals with diabetes and other conditions to measure their blood glucose levels without the need for skin pricks or traditional blood testing methods
  • In June 2022, Apollo Cancer Centers, in collaboration with Datar Cancer Genetics, introduced a blood test capable of detecting early-stage breast cancers in asymptomatic individuals.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Formulation & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objective
    • 1.9.1. Objective 1
    • 1.9.2. Objective2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing prevalence of target disease
      • 3.2.1.2. Growing demand for point-of-care tests
      • 3.2.1.3. Implementation of favorable government initiatives & external funding for R&D activities
      • 3.2.1.4. Introduction of CLIA waived tests
      • 3.2.1.5. Rising demand for early disease detection
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent regulatory and reimbursement policies
      • 3.2.2.2. Limitations associated with blood testing
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Collection Site Business Analysis

  • 4.1. Blood Testing Market: Collection Site Dashboard
  • 4.2. Blood Testing Market: Collection Site Movement Analysis
  • 4.3. Blood Testing Market by Collection Site, Revenue
  • 4.4. Glucose Testing
    • 4.4.1. Glucose Testing Market, 2018 - 2030 (USD Million)
  • 4.5. A1C Testing
    • 4.5.1. A1C Testing Market, 2018 - 2030 (USD Million)
  • 4.6. Direct LDL Testing
    • 4.6.1. Direct LDL Testing Market, 2018 - 2030 (USD Million)
  • 4.7. Lipid Panel Testing
    • 4.7.1. Lipid Panel Testing Market, 2018 - 2030 (USD Million)
  • 4.8. Prostate Specific Antigen Testing
    • 4.8.1. Prostate Specific Antigen Testing Market, 2018 - 2030 (USD Million)
  • 4.9. COVID-19 Testing
    • 4.9.1. COVID-19 Testing Market, 2018 - 2030 (USD Million)
  • 4.10. BUN Testing
    • 4.10.1. BUN Testing Market, 2018 - 2030 (USD Million)
  • 4.11. Vitamin D Testing
    • 4.11.1. Vitamin D Testing Market, 2018 - 2030 (USD Million)
  • 4.12. Thyroid Stimulating Hormone (TSH) Testing
    • 4.12.1. Thyroid Stimulating Hormone (TSH) Testing Market, 2018 - 2030 (USD Million)
  • 4.13. Serum Nicotine/Cotinine Testing
    • 4.13.1. Serum Nicotine/Cotinine Testing Market, 2018 - 2030 (USD Million)
  • 4.14. High Sensitivity CRP Testing
    • 4.14.1. High Sensitivity CRP Testing Market, 2018 - 2030 (USD Million)
  • 4.15. Testosterone Testing
    • 4.15.1. Testosterone Testing Market, 2018 - 2030 (USD Million)
  • 4.16. ALT Testing
    • 4.16.1. ALT Testing Market, 2018 - 2030 (USD Million)
  • 4.17. Cortisol Testing
    • 4.17.1. Cortisol Testing Market, 2018 - 2030 (USD Million)
  • 4.18. Creatinine Testing
    • 4.18.1. Creatinine Testing Market, 2018 - 2030 (USD Million)
  • 4.19. AST Testing
    • 4.19.1. AST Testing Market, 2018 - 2030 (USD Million)
  • 4.20. Other Blood Tests
    • 4.20.1. Other Blood Tests Market, 2018 - 2030 (USD Million)

Chapter 5. Regional Business Analysis

  • 5.1. Blood Testing Market Share By Region, 2024 & 2030
  • 5.2. North America
    • 5.2.1. North America Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. Key Country Dynamics
      • 5.2.2.2. Competitive Scenario
      • 5.2.2.3. Regulatory Framework
      • 5.2.2.4. U.S. Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.2.3. Canada
      • 5.2.3.1. Key Country Dynamics
      • 5.2.3.2. Competitive Scenario
      • 5.2.3.3. Regulatory Framework
      • 5.2.3.4. Canada Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.2.4. Mexico
      • 5.2.4.1. Key Country Dynamics
      • 5.2.4.2. Competitive Scenario
      • 5.2.4.3. Regulatory Framework
      • 5.2.4.4. Mexico Blood Testing Market, 2018 - 2030 (USD Million)
  • 5.3. Europe
    • 5.3.1. Europe Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.2. UK
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Competitive Scenario
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. UK Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.3. Germany
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Competitive Scenario
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Germany Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.4. France
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Competitive Scenario
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. France Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.5. Italy
      • 5.3.5.1. Key Country Dynamics
      • 5.3.5.2. Competitive Scenario
      • 5.3.5.3. Regulatory Framework
      • 5.3.5.4. Italy Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.6. Spain
      • 5.3.6.1. Key Country Dynamics
      • 5.3.6.2. Competitive Scenario
      • 5.3.6.3. Regulatory Framework
      • 5.3.6.4. Spain Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.7. Sweden
      • 5.3.7.1. Key Country Dynamics
      • 5.3.7.2. Competitive Scenario
      • 5.3.7.3. Regulatory Framework
      • 5.3.7.4. Sweden Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.8. Norway
      • 5.3.8.1. Key Country Dynamics
      • 5.3.8.2. Competitive Scenario
      • 5.3.8.3. Regulatory Framework
      • 5.3.8.4. Norway Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.9. Denmark
      • 5.3.9.1. Key Country Dynamics
      • 5.3.9.2. Competitive Scenario
      • 5.3.9.3. Regulatory Framework
      • 5.3.9.4. Denmark Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.10. Russia
      • 5.3.10.1. Key Country Dynamics
      • 5.3.10.2. Competitive Scenario
      • 5.3.10.3. Regulatory Framework
      • 5.3.10.4. Russia Blood Testing Market, 2018 - 2030 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.4.2. China
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Competitive Scenario
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. China Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.4.3. India
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Competitive Scenario
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. India Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.4.4. Japan
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Competitive Scenario
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. Japan Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.4.5. Thailand
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Competitive Scenario
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Thailand Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.4.6. South Korea
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Competitive Scenario
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. South Korea Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.4.7. Singapore
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Competitive Scenario
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Singapore Blood Testing Market, 2018 - 2030 (USD Million)
  • 5.5. Latin America
    • 5.5.1. Latin America Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.5.2. Brazil
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Brazil Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.5.3. Argentina
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. Argentina Blood Testing Market, 2018 - 2030 (USD Million)
  • 5.6. MEA
    • 5.6.1. MEA Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.6.2. Saudi Arabia
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Saudi Arabia Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.6.3. South Africa
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. South Africa Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.6.4. UAE
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Competitive Scenario
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. UAE Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.6.5. Kuwait
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Competitive Scenario
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Kuwait Blood Testing Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategy Mapping
  • 6.3. Company Market Share Analysis, 2024
  • 6.4. Company Profiles/Listing
    • 6.4.1. Abbott
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.1.3. Collection Site Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. bioMerieux
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.2.3. Collection Site Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Quest Diagnostics Incorporated
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.3.3. Collection Site Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. Biomerica, Inc
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.4.3. Collection Site Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. BD
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.5.3. Collection Site Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. QIAGEN Siemens Healthineers AG
      • 6.4.6.1. Overview
      • 6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.6.3. Collection Site Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Danaher Corporation
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.7.3. Collection Site Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. Trinity Biotech Plc
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.8.3. Collection Site Benchmarking
      • 6.4.8.4. Strategic Initiatives